Hormonal contraceptives for contraception in overweight or obese women (Q24197670)

2

object named as

David A Grimes

0 references

Carolyn Westhoff

5

object named as

Carolyn Westhoff

0 references

Mario Chen

3

object named as

Mario Chen

0 references

author name string

Conrad Otterness

4

0 references

Alison Edelman

6

0 references

Frans M Helmerhorst

Cochrane Database of Systematic Reviews

7

0 references

publication date

30 April 2013

0 references

published in

0 references

cites work

Association between efficacy and body weight or body mass index for two low-dose oral contraceptives

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Comparison of a novel norgestimate/ethinyl estradiol oral contraceptive (Ortho Tri-Cyclen Lo) with the oral contraceptive Loestrin Fe 1/20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Bleeding patterns with monophasic and triphasic low-dose ethinyl estradiol combined oral contraceptives

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Pre-introductory clinical trials of Norplant implants: a comparison of seventeen countries' experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Effectiveness of Norplant implants through seven years: a large-scale study in China

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Contraceptive efficacy and safety of DMPA-SC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

The efficacy and safety of a low-dose, 91-day, extended-regimen oral contraceptive with continuous ethinyl estradiol

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Body weight does not impact pregnancy rates during use of a low-dose extended-regimen 91-day oral contraceptive

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. II. Expulsions and removals. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

The Contraceptive CHOICE Project: reducing barriers to long-acting reversible contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Evaluation of contraceptive efficacy and cycle control of a transdermal contraceptive patch vs an oral contraceptive: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Contraceptive efficacy and cycle control with the Ortho Evra/Evra transdermal system: the analysis of pooled data

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Effect of injectable and oral contraceptives on glucose and insulin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Study of Norplant implants in Shanghai: three-year experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Can we identify women at risk of pregnancy despite using emergency contraception? Data from randomized trials of ulipristal acetate and levonorgestrel

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Results from pooled Phase III studies of ulipristal acetate for emergency contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

International experience with NORPLANT and NORPLANT-2 contraceptives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Clinical performance of a new two-rod levonorgestrel contraceptive implant: a three-year randomized study with Norplant implants as controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Prolonged effectiveness of Norplant(R) capsule implants: a 7-year study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Efficacy, bleeding patterns, and side effects of a 1-year contraceptive vaginal ring

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

GRADE guidelines: 3. Rating the quality of evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Body mass index and risk for oral contraceptive failure: a case-cohort study in South Carolina

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

The role of body weight in oral contraceptive failure: results from the 1995 national survey of family growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Oral contraceptive effectiveness according to body mass index, weight, age, and other factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Effectiveness of oral contraceptive pills in a large U.S. cohort comparing progestogen and regimen

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Contraceptive considerations in obese women: release date 1 September 2009, SFP Guideline 20091.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic-pituitary-ovarian activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999-2010

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Combination contraceptives: effects on weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Family planning for obese women: challenges and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Progestin-only pills for contraception

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Body mass index, weight, and oral contraceptive failure risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Steroidal contraceptives: effect on carbohydrate metabolism in women without diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

The emerging epidemic of obesity in developing countries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Allocation concealment in randomised trials: defending against deciphering

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Follicular development and ovulation in extremely obese women receiving depo-medroxyprogesterone acetate subcutaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Levonorgestrel concentrations during 7 years of continuous use of Jadelle contraceptive implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Obesity and oral contraceptive pill failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Oral contraceptive failures and body weight: findings in a large cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Pharmacokinetics and ovarian suppression during use of a contraceptive vaginal ring in normal-weight and obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Predictors of noncompliance in an oral contraceptive clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. I. Contraceptive efficacy and side effects. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

Microdose intravaginal levonorgestrel contraception: a multicentre clinical trial. III. The relationship between pregnancy rate and body weight. World Health Organization. Task Force on Long-Acting Systemic Agents for Fertility Regulation

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

Contraceptive efficacy, compliance and beyond: Factors related to satisfaction with once-weekly transdermal compared with oral contraception

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

Surrogate end points in women's health research: science, protoscience, and pseudoscience

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

Levonorgestrel concentrations during use of levonorgestrel rod (LNG ROD) implants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

A 10-year follow-up study of contraceptive Norplant implants

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

[Incidence of side effects of a 3-stage preparation administered to 10,034 women]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021

Obesity and oral contraceptive failure: findings from the 2002 National Survey of Family Growth

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008452.PUB3

7 January 2021